P Jimenez-Fonseca1, C Calderon2, A Carmona-Bayonas3, M M Muñoz4, R Hernández5, M Mut Lloret6, I Ghanem7, C Beato8, D Cacho Lavín9, A Ivars Rubio3, R Carrión10, C Jara11. 1. Department of Medical Oncology, Hospital Universitario Central de Asturias, Planta-1, Bloque D, Avenida Roma sn, 33011, Oviedo, Spain. palucaji@hotmail.com. 2. Department of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain. 3. Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain. 4. Department of Medical Oncology, Hospital Virgen de La Luz, Cuenca, Spain. 5. Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain. 6. Department of Medical Oncology, Hospital Universitario Son Espases, Mallorca, Spain. 7. Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. 8. Department of Medical Oncology, Hospital Universitario Virgen de La Macarena, Sevilla, Spain. 9. Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. 10. Department of Medical Oncology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain. 11. Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain.
Abstract
PURPOSE: The aim of this study was to analyze differences in physician and patient satisfaction in shared decision-making (SDM); patients' emotional distress, and coping in subjects with resected, non-metastatic cancer. METHODS: 602 patients from 14 hospitals in Spain were surveyed. Information was collected regarding physician and patient satisfaction with SDM, participants' emotional distress and coping, as well as patient sociodemographic and clinical characteristics by means of specific, validated questionnaires. RESULTS: Overall, 11% of physicians and 19% of patients were dissatisfied with SDM; 22% of patients presented hopelessness or anxious preoccupation as coping strategies, and 56% presented emotional distress. By gender, female patients showed a higher prevalence of dissatisfaction with SDM (23 vs 14%), anxious preoccupation (26 vs 17%), and emotional distress (63 vs 44%) than males. Hopelessness was more prevalent in individuals with stage III disease than those with stages I-II (28 vs 18%). CONCLUSION: Physicians must be mindful of the importance of emotional support and individual characteristics when communicating treatment options, benefits, and adverse effects of each alternative to oncological patients.
PURPOSE: The aim of this study was to analyze differences in physician and patient satisfaction in shared decision-making (SDM); patients' emotional distress, and coping in subjects with resected, non-metastatic cancer. METHODS: 602 patients from 14 hospitals in Spain were surveyed. Information was collected regarding physician and patient satisfaction with SDM, participants' emotional distress and coping, as well as patient sociodemographic and clinical characteristics by means of specific, validated questionnaires. RESULTS: Overall, 11% of physicians and 19% of patients were dissatisfied with SDM; 22% of patients presented hopelessness or anxious preoccupation as coping strategies, and 56% presented emotional distress. By gender, female patients showed a higher prevalence of dissatisfaction with SDM (23 vs 14%), anxious preoccupation (26 vs 17%), and emotional distress (63 vs 44%) than males. Hopelessness was more prevalent in individuals with stage III disease than those with stages I-II (28 vs 18%). CONCLUSION: Physicians must be mindful of the importance of emotional support and individual characteristics when communicating treatment options, benefits, and adverse effects of each alternative to oncological patients.
Entities:
Keywords:
Cancer; Coping; Distress; Medical oncologist; Satisfaction; Shared decision-making
Authors: D Simon; G Schorr; M Wirtz; A Vodermaier; C Caspari; B Neuner; C Spies; T Krones; H Keller; A Edwards; A Loh; M Härter Journal: Patient Educ Couns Date: 2006-07-26
Authors: N Padilla-Garrido; F Aguado-Correa; M Ortega-Moreno; J Bayo-Calero; E Bayo-Lozano Journal: An Sist Sanit Navar Date: 2017-04-30 Impact factor: 0.829
Authors: Lone Ross; Morten Aagaard Petersen; Anna Thit Johnsen; Louise Hyldborg Lundstrøm; Mogens Groenvold Journal: Support Care Cancer Date: 2012-06-08 Impact factor: 3.603
Authors: Sally Thorne; T Gregory Hislop; Charmaine Kim-Sing; Valerie Oglov; John L Oliffe; Kelli I Stajduhar Journal: Support Care Cancer Date: 2013-11-28 Impact factor: 3.603
Authors: C Calderon; A Carmona-Bayonas; R Hernandez; B Castelo; S Varma; O Donnay; D Gomez; P Jimenez-Fonseca Journal: Clin Transl Oncol Date: 2019-02-02 Impact factor: 3.405